North Point Portfolio Managers Corp Abbott Laboratories Transaction History

North Point Portfolio Managers Corp

$590 Million
Q3 2024

A detailed history of North Point Portfolio Managers Corp transactions in Abbott Laboratories stock. As of the latest transaction made, North Point Portfolio Managers Corp holds 100,487 shares of ABT stock, worth $11.8 Million. This represents 1.94% of its overall portfolio holdings.

Number of Shares

100,487

Previous 101,848 1.34%

Holding current value

$11.8 Million

Previous $10.6 Million 8.25%

% of portfolio

1.94%

Previous 1.88%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$100.07 - $118.13 $136,195 - $160,774	-1,361 Reduced 1.34%	100,487 $11.5 Million
Q2 2024 Jul 29, 2024	SELL	$100.73 - $112.44 $37,572 - $41,940	-373 Reduced 0.36%	101,848 $10.6 Million
Q1 2024 Apr 23, 2024	SELL	$109.52 - $120.96 $201,735 - $222,808	-1,842 Reduced 1.77%	102,221 $11.6 Million
Q4 2023 Jan 23, 2024	SELL	$90.19 - $110.4 $80,990 - $99,139	-898 Reduced 0.86%	104,063 $11.5 Million
Q3 2023 Oct 26, 2023	SELL	$95.53 - $114.62 $20,634 - $24,757	-216 Reduced 0.21%	104,961 $10.2 Million
Q2 2023 Jul 24, 2023	SELL	$100.78 - $112.29 $2.95 Million - $3.28 Million	-29,245 Reduced 21.76%	105,177 $11.5 Million
Q1 2023 Apr 25, 2023	BUY	$96.86 - $114.01 $80,878 - $95,198	835 Added 0.63%	134,422 $13.6 Million
Q4 2022 Jan 24, 2023	BUY	$95.06 - $111.52 $82,512 - $96,799	868 Added 0.65%	133,587 $0
Q3 2022 Oct 25, 2022	SELL	$96.76 - $112.03 $198,164 - $229,437	-2,048 Reduced 1.52%	132,719 $12.8 Million
Q2 2022 Jul 27, 2022	SELL	$102.07 - $123.37 $156,575 - $189,249	-1,534 Reduced 1.13%	134,767 $14.6 Million
Q1 2022 Apr 26, 2022	SELL	$114.02 - $139.04 $9,919 - $12,096	-87 Reduced 0.06%	136,301 $16.1 Million
Q4 2021 Jan 26, 2022	SELL	$115.53 - $141.46 $493,197 - $603,892	-4,269 Reduced 3.04%	136,388 $19.2 Million
Q3 2021 Oct 20, 2021	SELL	$116.66 - $129.06 $217,454 - $240,567	-1,864 Reduced 1.31%	140,657 $16.6 Million
Q2 2021 Jul 28, 2021	SELL	$105.79 - $124.53 $42,739 - $50,310	-404 Reduced 0.28%	142,521 $16.5 Million
Q1 2021 Apr 26, 2021	SELL	$108.84 - $128.23 $45,603 - $53,728	-419 Reduced 0.29%	142,925 $17.1 Million
Q4 2020 Jan 28, 2021	BUY	$105.0 - $114.42 $6,825 - $7,437	65 Added 0.05%	143,344 $15.7 Million
Q3 2020 Oct 27, 2020	SELL	$91.64 - $111.29 $194,460 - $236,157	-2,122 Reduced 1.46%	143,279 $15.6 Million
Q2 2020 Jul 28, 2020	SELL	$76.57 - $98.0 $512,789 - $656,306	-6,697 Reduced 4.4%	145,401 $13.3 Million
Q1 2020 Apr 28, 2020	SELL	$62.82 - $91.86 $320,067 - $468,026	-5,095 Reduced 3.24%	152,098 $12 Million
Q4 2019 Feb 20, 2020	SELL	$78.51 - $87.4 $636,637 - $708,726	-8,109 Reduced 4.91%	157,193 $13.7 Million
Q3 2019 Oct 31, 2019	SELL	$81.84 - $88.74 $160,242 - $173,752	-1,958 Reduced 1.17%	165,302 $13.8 Million
Q2 2019 Aug 02, 2019	SELL	$72.88 - $85.0 $34,326 - $40,035	-471 Reduced 0.28%	167,260 $14.1 Million
Q1 2019 Apr 24, 2019	SELL	$66.22 - $80.06 $2.75 Million - $3.33 Million	-41,588 Reduced 19.87%	167,731 $13.4 Million
Q4 2018 Jan 24, 2019	SELL	$65.56 - $74.27 $1.12 Million - $1.27 Million	-17,055 Reduced 7.53%	209,319 $15.1 Million
Q3 2018 Oct 26, 2018	SELL	$60.81 - $73.36 $382,920 - $461,947	-6,297 Reduced 2.71%	226,374 $16.6 Million
Q2 2018 Jul 26, 2018	SELL	$57.57 - $63.54 $341,908 - $377,364	-5,939 Reduced 2.49%	232,671 $14.2 Million
Q1 2018 Apr 25, 2018	SELL	$56.27 - $63.62 $62,572 - $70,745	-1,112 Reduced 0.46%	238,610 $14.3 Million
Q4 2017 Jan 24, 2018	SELL	$53.68 - $57.47 $554,192 - $593,320	-10,324 Reduced 4.13%	239,722 $13.7 Million
Q3 2017 Oct 30, 2017	BUY	$48.06 - $53.64 $12 Million - $13.4 Million	250,046	250,046 $13.3 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Point Portfolio Managers Corp, based on Form 13F filings with the SEC.

News

Stay updated on North Point Portfolio Managers Corp with notifications on news.

Account

North Point Portfolio Managers Corp Abbott Laboratories Transaction History